Analysts See 345% Upside in RUM

RUM Rumble grabbed 345% analyst upside potential today. The $1.7B video platform held just two analysts covering the stock showing sparse Street attention. Bears piled in at 24.9% SI with 24.4 days to cover.

LFVN LifeVantage analysts saw 91% upside despite 44% short interest. The $54M personal care name topped short score rankings at 94 with cost to borrow hitting 19.5%. Just one analyst covered the stock.

CRDF Cardiff Oncology drew eight analysts projecting 391% returns. The $108M biotech held 26.4% SI as bears faced 24.8 days to cover. Short score hit 89 showing extreme positioning.

MVIS MicroVision analysts pegged 220% upside potential. The $192M sensor maker held 22.7% SI with cost to borrow at 25%. Three analysts covered the heavily shorted name.

Trip.com topped broad analyst optimism rankings with 939% projected returns. The $33B travel giant held $32B market cap yet analysts saw massive upside. TCOM China Yuchai grabbed 854% upside potential from Street analysts.

Small-cap biotechs and heavily shorted names dominated extreme upside calls showing Street conviction in turnaround stories.